Long-term follow-up of therapy with intermittent etidronate disodium in paget's disease of bone
- 1 November 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (5) , 583-590
- https://doi.org/10.1016/0002-9343(85)90055-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Bone Tissue in Faget??s Disease Treated by Ethane-1, Hydroxy-1, 1 Diphosphonate (EHDP)Published by Wolters Kluwer Health ,1984
- Treatment of Paget's Disease of Bone with Ethane-1, Hydroxy-1,1 Diphosphonate (EHDP) at a Low Dosage (5 mg/kg/day)Published by Wolters Kluwer Health ,1983
- Review of Fracture Experience During Treatment of Paget??s Disease of Bone with Etidronate Disodium (EHDP)Published by Wolters Kluwer Health ,1983
- Clinical and biochemical effects of EHDP in Paget's disease of bone: Patterns of response to initial treatment and to long-term therapyMetabolic Bone Disease and Related Research, 1981
- Mithramycin treatment of pacet's disease of bone exploration of combined mithramycin-ehdp therapyArthritis & Rheumatism, 1980
- Long‐term therapy of paget's disease of bone with ehdpArthritis & Rheumatism, 1980
- Experimental basis for the clinical use of diphosphonates in paget's disease of boneArthritis & Rheumatism, 1980
- Use of etidronate (ehdp) in paget's disease of boneArthritis & Rheumatism, 1980
- DIPHOSPHONATES AND PAGET'S DISEASE OF BONEThe Lancet, 1971
- Radiological Assessment of Osteo-ArthrosisAnnals of the Rheumatic Diseases, 1957